By: IPP Bureau
Last updated : July 20, 2026 4:14 pm
18-month initiative aims to strengthen TB diagnosis, prevention and patient support in alignment with India's National Tuberculosis Elimination Programme
Mylan Laboratories Limited, a part of global healthcare company Viatris, has launched a new tuberculosis (TB) support project in Nagpur, Maharashtra, with a special focus on drug-resistant tuberculosis (DR-TB).
The 18-month initiative is being implemented in partnership with Doctors For You, the Nagpur Municipal Corporation, and the City TB Office, Nagpur under a Public-Private Partnership (PPP) model. It is aligned with the Government of India's National Tuberculosis Elimination Programme (NTEP) and follows its Detect-Treat-Prevent-Build strategy.
The project seeks to address persistent challenges in Nagpur district, including expanding TB preventive treatment coverage and strengthening molecular diagnostic capacity.
Key interventions include timely and accurate diagnosis, improved uptake of TB preventive treatment among household contacts, nutritional support for TB and DR-TB patients, and enhanced coordination across diagnostic, preventive and patient support services.
As part of the programme, more than 26,000 TB diagnostic samples will be processed across four locations in Nagpur district. The initiative also aims to conduct household contact tracing for confirmed TB and DR-TB patients, covering around 22,000 households, and distribute more than 450 nutrition kits to patients.
Lina Andersson, Head of Global Sustainability, Viatris, said, "Since 2020, we've screened more than 1.5 million people for TB in India. Over the past five years, Viatris supported the TB Control Initiative, reaching more than 58,000 people in rural and tribal areas of Gadchiroli district, Maharashtra. We will continue to explore ways to support regional and national health priorities and look forward to continued collaboration for the health and well-being of people in Maharashtra."
Dr. Abhijit Deshmukh, Head of Global Non-Sterile Operations, Viatris, said, "As a company with a long-standing presence in Maharashtra, we are committed to supporting the health and wellbeing of the communities where our colleagues live and work. Through this partnership, we aim to strengthen local efforts to improve TB detection, prevention and patient support, contributing to the broader goal of eliminating tuberculosis in India."